ZyVersa Therapeutics, Inc. (ZVSA)
OTCMKTS · Delayed Price · Currency is USD
0.1050
-0.0110 (-9.48%)
At close: Jul 30, 2026
ZyVersa Therapeutics Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 |
Operating Income Operating Income Growth | -1.3 | -0.55 | -2.1 | -2.04 | -2.14 | -1.29 | -2.27 | -2.75 | -2.83 | -1.78 | -2.9 | -5.15 | -4.59 | -5.19 | -3.4 | -1.88 | -3.37 | -1.78 | -2.11 | -1.85 |
Net Income Net Income Growth | -1.79 | -0.68 | -19.81 | -2.21 | -2.26 | -1.42 | -2.4 | -2.76 | -2.83 | -13.34 | -2.93 | -86.43 | -3.54 | 5.34 | -13.38 | -2.34 | -3.75 | -1.97 | -1.88 | -2.1 |
Earnings Per Share EPS Growth | -0.22 | -0.08 | -2.56 | -0.46 | -0.73 | -0.71 | -2.43 | -3.31 | -4.53 | -62.08 | -30.18 | -1694.12 | -135.88 | 0.06 | -193.74 | -33.82 | -54.29 | -0.21 | -27.23 | -30.34 |
EPS Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Fiscal Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 0.3 | 0.1 | 0.53 | 0.07 | 1.61 | 1.53 | 0.12 | 0.12 | 2.03 | 3.14 | 1.58 | 0.23 | 1.28 | 5.9 | 0.6 | 0.03 | 0.35 | 0.33 | - | - |
Total Debt Total Debt Growth | 1.2 | - | - | - | - | - | - | - | - | 0.01 | 0.03 | 0.06 | 0.08 | 0.11 | 3.96 | 9.19 | 9.18 | 9.15 | - | - |
Net Cash (Debt) Net Cash Growth | -0.9 | 0.1 | 0.53 | 0.07 | 1.61 | 1.53 | 0.12 | 0.12 | 2.03 | 3.13 | 1.54 | 0.17 | 1.19 | 5.79 | -3.36 | -9.16 | -8.84 | -8.82 | - | - |
Net Cash Growth | - | -93.35% | 329.53% | -39.67% | -20.75% | -51.07% | -92.04% | -29.33% | 70.38% | -45.99% | - | - | - | - | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.11 | 0.01 | 0.07 | 0.01 | 0.52 | 0.77 | 0.12 | 0.14 | 3.26 | 14.56 | 15.88 | 3.31 | 45.76 | 0.06 | -48.64 | -132.61 | -127.96 | -0.93 | - | - |
| Fiscal Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -0.8 | -0.41 | -1.41 | -1.52 | -1.77 | -1.21 | -0.61 | -1.91 | -3.78 | -2.79 | -0.94 | -0.41 | -4.59 | -3.81 | -0.39 | -0.32 | -0.37 | -0.62 | -0.7 | -1.5 |
Free Cash Flow Free Cash Flow Growth | -0.8 | -0.41 | -1.41 | -1.52 | -1.77 | -1.21 | -0.61 | -1.91 | -3.78 | -2.79 | -0.94 | -0.41 | -4.59 | -3.81 | -0.39 | -0.32 | -0.37 | -0.62 | -0.7 | -1.5 |
Free Cash Flow Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Selected indicators aren't available for this stock.